Program Project Scores Have Compressed Review Shuld Return To Rank Order; Broder
In Brief: Former ICCCR Staff Form International Marketing Firm; M.D. Andersons Names New Professorship
P01 Reviewers Asked To Look Closely At Number Of Projects
Three-Quarters of P01 $$ Goes To Translational Grants, NCI Finds
Slow Accruing Trials Should Be Removed From High Priority Program, Broder Says
Score Distribution, Other Charts, On P01s
In Congress; Senate Ok’s $185 Mil. Addition For Breast Cancer
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- The Directors: New directors Herbst and Gius chart a future built on AI, collaboration, and rural access
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial - Consumers are increasingly accessing U.S. News rankings of cancer hospitals via AI chatbots
2026 report shows no change in the top-five lineup - What happened at FDA? Replimune approval raises questions









